课题基金 / 基金详情

PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION

PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
蛋白质相关 DNA 断裂作为拓扑异构酶抑制的指标
批准号:
6160983
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Y POMMIER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DNA topoisomerase I (top1) has become an essential target for anticancer research since the discovery that camptothecins are specific top1 poisons and exhibit promising anticancer activity. Camptothecins act by stabilizing top1-linked DNA breaks (cleavable complexes) which can be detected as protein-associated DNA breaks in drug-treated cells. Our studies are aimed at addressing several fundamental questions regarding the top1 cleavable complexes: (1) what are the molecular interactions between camptothecins and top1? (2) Can we discover and characterize new top1 inhibitors? (3) Are cleavable complexes trapped by other DNA alterations (base modifications, mismatches, DNA breaks, gaps...)? (4) How are the trapped cleavable complexes processed in cells and subcellular systems; and (3) what is the role(s) of topoisomerases in some cellular responses to DNA damage and apoptosis. Molecular interactions between camptothecins and top1 cleavable complexes have been addressed using an alkylating camptothecin derivative and a camptothecin- resistant point mutant top1. Both experimental approaches provide the most direct evidence that camptothecins block top1 by binding at the enzyme/DNA interface. Molecular modeling is consistent with this hypothesis. Two novel families of top1 inhibitors have been discovered in collaboration with outside groups: NSC 314622 by the COMPARE algorithm in the NCI Drug Screen, and aclarubicin by yeast screening. Cleavable complexes induce DNA damage after interference with replication and possibly transcription complexes. The resulting lesions are irreversible DNA breaks and top1 suicide complexes which are potentially recombinogenic. The processing (repair) of such lesions is yet unknown and is a goal of our studies. We are collaborating with Howard Nash (NIMH). In the absence of removal of cleavable complexes, top1 can kill cells (camptothecin-mimetic) or act as a DNA strand transferase and induce DNA recombinations. These effect are relevant to the cytotoxicity of camptothecins or other top1 poisons used in cancer treatment and to the cellular functions of top1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
  • 批准号:
    3916548
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
  • 批准号:
    3939497
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
  • 批准号:
    3838171
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
  • 批准号:
    3752315
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
海外基金